MaxCyte Inc
NASDAQ:MXCT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
MaxCyte Inc
NASDAQ:MXCT
|
US |
|
Mentice AB
F:MN2
|
SE |
|
K
|
Konami Group Corp
XMUN:KOA
|
JP |
|
N
|
Novus Holdings Ltd
JSE:NVS
|
ZA |
|
E
|
El Pollo Loco Holdings Inc
F:EP6
|
US |
|
S
|
Scotts Miracle-Gro Co
F:SCQA
|
US |
|
K
|
Koninklijke Philips NV
DUS:PHIA
|
NL |
|
Brunello Cucinelli SpA
MIL:BC
|
IT |
Wall St Price Targets
MXCT Price Targets Summary
MaxCyte Inc
According to Wall Street analysts, the average 1-year price target for MXCT is 4.19 USD with a low forecast of 2.45 USD and a high forecast of 5.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MXCT's stock price target?
Price Target
4.19
USD
According to Wall Street analysts, the average 1-year price target for MXCT is 4.19 USD with a low forecast of 2.45 USD and a high forecast of 5.25 USD.
What is the Revenue forecast for MaxCyte Inc?
Projected CAGR
32%
Over the last 12 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 8 years is 32%.
What is the Gross Profit forecast for MaxCyte Inc?
Projected CAGR
6%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 2 years is 6%.
